263 related articles for article (PubMed ID: 12879430)
1. Early lymphopenia as a risk factor for chemotherapy-induced febrile neutropenia.
Choi CW; Sung HJ; Park KH; Yoon SY; Kim SJ; Oh SC; Seo JH; Kim BS; Shin SW; Kim YH; Kim JS
Am J Hematol; 2003 Aug; 73(4):263-6. PubMed ID: 12879430
[TBL] [Abstract][Full Text] [Related]
2. Which one is a risk factor for chemotherapy-induced febrile neutropenia in childhood solid tumors: early lymphopenia or monocytopenia?
Oguz A; Karadeniz C; Ckitak EC; Cil V
Pediatr Hematol Oncol; 2006 Mar; 23(2):143-51. PubMed ID: 16651243
[TBL] [Abstract][Full Text] [Related]
3. CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancer.
Borg C; Ray-Coquard I; Philip I; Clapisson G; Bendriss-Vermare N; Menetrier-Caux C; Sebban C; Biron P; Blay JY
Cancer; 2004 Dec; 101(11):2675-80. PubMed ID: 15503313
[TBL] [Abstract][Full Text] [Related]
4. Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia.
Blay JY; Chauvin F; Le Cesne A; Anglaret B; Bouhour D; Lasset C; Freyer G; Philip T; Biron P
J Clin Oncol; 1996 Feb; 14(2):636-43. PubMed ID: 8636781
[TBL] [Abstract][Full Text] [Related]
5. Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study.
Ammann RA; Bodmer N; Hirt A; Niggli FK; Nadal D; Simon A; Ozsahin H; Kontny U; Kühne T; Popovic MB; Lüthy AR; Aebi C
J Clin Oncol; 2010 Apr; 28(12):2008-14. PubMed ID: 20231680
[TBL] [Abstract][Full Text] [Related]
6. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
Ghalaut PS; Sen R; Dixit G
J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
[TBL] [Abstract][Full Text] [Related]
7. Retrospective cost analysis of management of febrile neutropenia in cancer patients in Spain.
Mayordomo JI; López A; Viñolas N; Castellanos J; Pernas S; Domingo Alonso J; Frau A; Layola M; Antonio Gasquet J; Sánchez J;
Curr Med Res Opin; 2009 Oct; 25(10):2533-42. PubMed ID: 19722781
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of mannose-binding lectin and the risk of fever in neutropenia pediatric cancer patients.
Schlapbach LJ; Aebi C; Otth M; Luethy AR; Leibundgut K; Hirt A; Ammann RA
Pediatr Blood Cancer; 2007 Jul; 49(1):11-6. PubMed ID: 17143875
[TBL] [Abstract][Full Text] [Related]
9. Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy.
Shayne M; Culakova E; Poniewierski MS; Wolff D; Dale DC; Crawford J; Lyman GH
Cancer; 2007 Oct; 110(7):1611-20. PubMed ID: 17705197
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of once-per-cycle administration pegylated recombinant human granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in a phase I trial].
Yang S; Shi YK; Liu P; Han XH; He XH; Cai YM; Chen ZM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):339-44. PubMed ID: 16900629
[TBL] [Abstract][Full Text] [Related]
11. Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.
Timmer-Bonte JN; de Boo TM; Smit HJ; Biesma B; Wilschut FA; Cheragwandi SA; Termeer A; Hensing CA; Akkermans J; Adang EM; Bootsma GP; Tjan-Heijnen VC
J Clin Oncol; 2005 Nov; 23(31):7974-84. PubMed ID: 16258098
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of mannose-binding lectin-associated serine protease-2 associated with increased risk of fever and neutropenia in pediatric cancer patients.
Schlapbach LJ; Aebi C; Otth M; Leibundgut K; Hirt A; Ammann RA
Pediatr Infect Dis J; 2007 Nov; 26(11):989-94. PubMed ID: 17984804
[TBL] [Abstract][Full Text] [Related]
13. The use and effectiveness of granulocyte colony-stimulating factor in primary prophylaxis for febrile neutropenia in the outpatient setting.
Tuffaha HW; Treish IM; Zaru L
J Oncol Pharm Pract; 2008 Sep; 14(3):131-8. PubMed ID: 18524866
[TBL] [Abstract][Full Text] [Related]
14. Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas.
Ray-Coquard I; Ghesquière H; Bachelot T; Borg C; Biron P; Sebban C; LeCesne A; Chauvin F; Blay JY;
Br J Cancer; 2001 Sep; 85(6):816-22. PubMed ID: 11556830
[TBL] [Abstract][Full Text] [Related]
15. Retrospective review of gynecologic oncology patients with therapy-induced neutropenic fever.
McMeekin DS; Gazzaniga C; Berman M; DiSaia P; Manetta A
Gynecol Oncol; 1996 Aug; 62(2):247-53. PubMed ID: 8751557
[TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group.
Ozkaynak MF; Krailo M; Chen Z; Feusner J
Pediatr Blood Cancer; 2005 Sep; 45(3):274-80. PubMed ID: 15806544
[TBL] [Abstract][Full Text] [Related]
17. A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia.
Rondinelli PI; Ribeiro Kde C; de Camargo B
J Pediatr Hematol Oncol; 2006 Oct; 28(10):665-70. PubMed ID: 17023827
[TBL] [Abstract][Full Text] [Related]
18. Risk of mortality in patients with cancer who experience febrile neutropenia.
Lyman GH; Michels SL; Reynolds MW; Barron R; Tomic KS; Yu J
Cancer; 2010 Dec; 116(23):5555-63. PubMed ID: 20715160
[TBL] [Abstract][Full Text] [Related]
19. Risk index score for bacteremia in febrile neutropenic episodes in children with malignancies.
Spasova MI; Grudeva-Popova JG; Kostyanev SS; Genev ED; Stoyanova AA; Kirina VI; Moumdjiev IN
J BUON; 2009; 14(3):411-8. PubMed ID: 19810131
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients.
Oude Nijhuis C; Kamps WA; Daenen SM; Gietema JA; van der Graaf WT; Groen HJ; Vellenga E; Ten Vergert EM; Vermeulen KM; de Vries-Hospers HG; de Bont ES
J Clin Oncol; 2005 Oct; 23(30):7437-44. PubMed ID: 16234511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
